Monoclonal Antibody Risankizumab for Ulcerative Colitis
The inflammatory bowel diseases of ulcerative colitis and Crohn disease are chronic inflammatory conditions of the intestine. The estimated incidence of ulcerative colitis is 15 per 100 000 person-years and the prevalence is 400 per 100 000 in North America. Despite advances to medical management, nearly 1 in 5 patients with ulcerative colitis will be hospitalized and approximately 7% will require a colectomy within 5 years of diagnosis. The health care cost of ulcerative colitis has steadily risen over the past 2 decades... Читать дальше...